34 episodes

No one in the medical field is free from the impact of COVID-19, including gastroenterologists. But the pandemic has only accelerated trends that started years ago. In this podcast, Praveen Suthrum interviews leaders in the gastroenterology space. Each episode will take you through different perspectives and help you ask the right questions. Praveen is the President of NextServices and author of Private Equity in Gastroenterology and Scope Forward (both Amazon #1 new releases).

Scope Forward Praveen Suthrum

    • Health & Fitness
    • 5.0 • 3 Ratings

No one in the medical field is free from the impact of COVID-19, including gastroenterologists. But the pandemic has only accelerated trends that started years ago. In this podcast, Praveen Suthrum interviews leaders in the gastroenterology space. Each episode will take you through different perspectives and help you ask the right questions. Praveen is the President of NextServices and author of Private Equity in Gastroenterology and Scope Forward (both Amazon #1 new releases).

    Matt Schwartz: Huge opportunity to add a digital layer to GI and endoscopy

    Matt Schwartz: Huge opportunity to add a digital layer to GI and endoscopy

    In this episode of The Scope Forward Show, Praveen Suthrum interviews Matt Schwartz CEO & Co-founder of Virgo.

    Virgo has captured 400,000 endoscopy videos so far and that number is growing exponentially. Virgo has also partnered with pharmaceutical companies to recruit the right candidates for clinical trials which led to a fundraise of $8 million with FCA Venture Partners and a soon-to-be-announced strategic investor.

    Watch this insightful interview to understand why 'data is the new oil' and how Virgo will dramatically influence GI care in the coming years-https://www.youtube.com/watch?v=5XUvl7RDzsQ

    #data #gastroenterology #scopeforward #endoscopy #AI #clinicaltrials

    • 38 min
    Dr. Fehmida Chipty: From GI doc to COO of digital health startup

    Dr. Fehmida Chipty: From GI doc to COO of digital health startup

    In this episode of The Scope Forward Show, Praveen Suthrum interviews Fehmida Chipty, MD, COO of digital health startup Satya Health Sciences | NovoLiver.

    Watch Dr. Fehmida Chipty's fascinating narration unfold fundamental issues of #gastroenterology. Why did she quit GI? What are the problems that we don't talk about? Why don't physicians ask for help? What her concerns are with our healthcare system? Is doing #colonoscopy after colonoscopy really helping solve for cancer?


    Your future self will want you to watch this one.

    • 37 min
    Abe M'Bodj: How Will Private Equity Respond To Recession?

    Abe M'Bodj: How Will Private Equity Respond To Recession?

    In this episode of The Scope Forward Show, Praveen Suthrum interviews Abe M'Bodj, Vice President at Westcove Partners, a leading healthcare-focused investment bank. During an economic downturn, would PE investments increase or drop? About 10% of the entire gastroenterology industry is under some form of PE as of mid-2022. What effect would recession have on "second bites" (exits) of existing PE platforms? What impact would it have on valuations? What big announcements can we expect before the end of the year? Find out more in this exclusive interview.

    • 43 min
    Aonghus Shortt: "If you capture more data, you should be able to do a better diagnosis."

    Aonghus Shortt: "If you capture more data, you should be able to do a better diagnosis."

    We are back with the next season of The Scope Forward Show where you'll get to meet innovators and leaders who are reimagining the healthcare system.

    The next phase of GI depends on innovators such as Aonghus and FoodMarble. Why? Because the industry is shifting from under our feet. Four trends are influencing GI: exponential technologies, consolidation, big brothers (such as hospitals, insurances) and changes in patient behavior.

    FoodMarble, a tiny device that analyzes digestive disorders such as IBS and SIBO, comes squarely in the middle of these trends. After selling 30,000 devices, what do they know about patients with IBS that a private practice does not? How can this be a new revenue-generating ancillary opportunity? 

    The story of its growth is also interesting. An engineer gets an idea after seeing his girlfriend suffer. Ideates and develops the device in Ireland and China. Raises $6 million and sells globally - more than 2/3rd in the US. It's indicative of how the next phase of innovation would happen.

    Aonghus says, with "more data", you can come up with a "better diagnosis". True. Welcome to the evolving world of data-driven GI.

    • 24 min
    Dr. Sravanthi Parasa: "When a phone can recognize my face, why can’t software recognize a polyp?"

    Dr. Sravanthi Parasa: "When a phone can recognize my face, why can’t software recognize a polyp?"

    Every so often an interview reminds me yet again that the future is coming at us faster -- much faster. I'm still wrapping my head around what gastroenterologist and AI researcher Dr. Sravanthi Parasa told me: there would be a "1,000 algorithms" in 3 years in GI.

    This is big implications for the business of gastroenterology. The AI will indeed operate and guide us like a self driving car. In such a world, how would your role evolve as the endoscopist? What would happen to all the PE valuations that are based on GI manual productivity? How would the workflow change when you combine liquid biopsy and AI? Would your practice prefer hiring an AI vs. an average endoscopist? What if the insurance mandates the use of AI?

    Welcome to GI 2.0.

    **

    Watch more interviews:  https://www.nextservices.com/interviews/

    **

    #gastroenterology #TheScopeForwardShow #nextservices​​ #scopeforward​​ #healthcare​​ #technology​​ #healthtech​​ #aiingi #artificialintelligence #digitalhealth

    • 35 min
    Sam Holliday (CEO of Oshi Health): "My goal would be to cover all 50 states by the end of 2022."

    Sam Holliday (CEO of Oshi Health): "My goal would be to cover all 50 states by the end of 2022."

    Praveen Suthrum interviews Sam Holliday, CEO of the digital health company, Oshi Health.  Two weeks ago, Oshi Health raised $23 million from well-known investors. It reinforces the fact that the landscape of gastroenterology is shifting toward digitization.  

    In this interview, Sam Holliday (CEO of Oshi Health) talks about their plans to scale across all 50 states by the end of 2022. They also plan to hire gastroenterologists and partner with GI practices. Learn about what's attracting investor interest in digitization of gastroenterology.

    **

    Watch more interviews:  https://www.nextservices.com/interviews/

    **

    #gastroenterology #TheScopeForwardShow #nextservices​​ #scopeforward​​ #healthcare​​ #technology​​ #healthtech​​ #leadership​ #digitalhealth #oshihealth #digitalhealth #digitalGI

    • 29 min

Customer Reviews

5.0 out of 5
3 Ratings

3 Ratings

Top Podcasts In Health & Fitness

Scicomm Media
Jay Shetty
Lewis Howes
Aubrey Gordon & Michael Hobbes
Rob Dial and Kast Media
Slumber Studios

You Might Also Like